We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$112M
2
RY icon
Royal Bank of Canada
RY
+$44.3M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.1M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$38.9M
5
MRK icon
Merck
MRK
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNDX icon
151
Syndax Pharmaceuticals
SNDX
$1.73B
$22.1M 0.15%
1,021,032
+781,022
+325% +$12M
VLO icon
152
Valero Energy
VLO
$89.1B
$21.2M 0.15%
162,754
-43,278
-21% -$5.51M
SHW icon
153
Sherwin-Williams
SHW
$87.3B
$21.1M 0.15%
67,648
-1,546
-2% -$416K
MS icon
154
Morgan Stanley
MS
$332B
$21.1M 0.15%
226,252
-273,560
-55% -$21.9M
OC icon
155
Owens Corning
OC
$11.7B
$20.8M 0.14%
140,266
-54,407
-28% -$7.21M
EXAS
156
DELISTED
Exact Sciences
EXAS
$20.6M 0.14%
278,670
+131,582
+89% +$8.62M
NUVL
157
DELISTED
Nuvalent
NUVL
$20.6M 0.14%
280,009
-70,008
-20% -$4.33M
APLS
158
DELISTED
Apellis Pharmaceuticals
APLS
$20.2M 0.14%
337,507
+11,000
+3% +$558K
ARVN icon
159
Arvinas
ARVN
$523M
$20.1M 0.14%
487,555
+40,004
+9% +$935K
FICO icon
160
Fair Isaac
FICO
$32B
$20M 0.14%
17,191
-5,612
-25% -$5.65M
EA icon
161
Electronic Arts
EA
$52.4B
$19.5M 0.13%
142,528
+32,831
+30% +$4.34M
IDXX icon
162
Idexx Laboratories
IDXX
$45.1B
$19.2M 0.13%
34,636
-599
-2% -$281K
JBL icon
163
Jabil
JBL
$31.1B
$19.2M 0.13%
150,823
-22,367
-13% -$2.85M
CL icon
164
Colgate-Palmolive
CL
$75.5B
$18.7M 0.13%
233,977
-216,005
-48% -$16.2M
NFLX icon
165
Netflix
NFLX
$305B
$18.5M 0.13%
379,540
+34,170
+10% +$1.49M
EXC icon
166
Exelon
EXC
$49.1B
$18.4M 0.13%
512,636
+386,987
+308% +$14.9M
WELL icon
167
Welltower
WELL
$173B
$18.3M 0.13%
202,559
+157,845
+353% +$13.7M
RY icon
168
Royal Bank of Canada
RY
$293B
$18.2M 0.13%
178,751
-502,411
-74% -$44.3M
ZBRA icon
169
Zebra Technologies
ZBRA
$13B
$18.1M 0.13%
66,317
-2,170
-3% -$495K
KRTX
170
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$18.1M 0.13%
57,201
-4,000
-7% -$778K
EBAY icon
171
eBay
EBAY
$51.8B
$18M 0.12%
412,349
-87,251
-17% -$3.61M
HASI icon
172
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.91B
$17.8M 0.12%
647,075
+87,970
+16% +$1.92M
BLD
173
DELISTED
TopBuild
BLD
$17.8M 0.12%
47,451
-13,005
-22% -$3.72M
SRPT icon
174
Sarepta Therapeutics
SRPT
$1.62B
$17.6M 0.12%
182,445
+46,736
+34% +$4.48M
WAB icon
175
Wabtec
WAB
$51.3B
$17.5M 0.12%
137,666
-8,780
-6% -$991K
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.